Back to Search
JUSTIN KREUTER, M.D.
M.D.
Blood Banking & Transfusion Medicine Physician
NPI: 1649498767IndividualAccepts Medicare
Specialties, Licenses & Credentials
Blood Banking & Transfusion Medicine PhysicianPrimary
Pathology — Blood Banking & Transfusion Medicine
Code: 207ZB0001X
105589(MN)54477(MN)
Anatomic Pathology & Clinical Pathology Physician
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
RT 1702(NH)
CMS Specialties
PrimaryPATHOLOGY
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 2007
Research & Publications (20)
Functional protein delivery into neurons using polymeric nanoparticles.
PMID 19129199·J Biol Chem·2009
7-preclinical
Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17beta-estradiol-hemihydrate.
PMID 19365781·Drug Dev Ind Pharm·2009
7-preclinical
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
PMID 19285109·J Control Release·2009
7-preclinical
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
PMID 18805484·Eur J Pharm Biopharm·2009
7-preclinical
Guest editorial: special issue for Prof. Dr. Peter Paul Speiser.
PMID 19586312·J Drug Target·2009
8-other
Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80.
PMID 19023984·Bull Exp Biol Med·2008
7-preclinical
Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles.
PMID 18937508·Bioconjug Chem·2008
8-other
T cells for suicide gene therapy: activation, functionality and clinical relevance.
PMID 18155021·J Immunol Methods·2008
8-other
Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles.
PMID 18295418·Int J Pharm·2008
8-other
Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats.
PMID 18374523·Toxicol Lett·2008
7-preclinical
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.
PMID 18246351·Cancer Chemother Pharmacol·2008
8-other
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity.
PMID 17349632·FEBS Lett·2007
8-other
Repeated amphetamine administration outside the home cage enhances drug-induced Fos expression in rat nucleus accumbens.
PMID 17720257·Behav Brain Res·2007
7-preclinical
Pharmacology of intracellular cytosine-arabinoside-5'-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes.
PMID 17171362·Cancer Chemother Pharmacol·2007
8-other
Stat scheduling. MedStar Health found replacing a fax-based system with clinical messaging was the answer to the OR scheduling challenge.
PMID 17990650·Healthc Inform·2007
8-other
Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity.
PMID 17306479·Int J Pharm·2007
4-observational
Is it really "buy vs. build"? Part 2: MedStar Health's clinician portal application--a build+build success story.
PMID 17260633·Healthc Inform·2007
8-other
Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
PMID 17250920·J Control Release·2007
4-observational
Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
PMID 17478065·Int J Pharm·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1649498767
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile